In vitro and in vivo evaluation of A-56268 (TE-031), a new macrolide

Prabhavathi Fernandes, Robert T. Bailer, R. N. Swanson, +7

Antimicrobial Agents and Chemotherapy

Antibacterial ActivityMolecular BiologyAntimicrobial ChemotherapyNew MacrolideDrug Resistance +15

Novel mechanism of macrolide resistance in Streptococcus pneumoniae

Virginia D. Shortridge, Robert K. Flamm, N Ramer, +2

Diagnostic Microbiology and Infectious Disease

Antimicrobial Resistance GeneHealth SciencesMicrobiologyAntibiotic ResistanceMedicine +4

Comparative antibacterial activities of temafloxacin hydrochloride (A-62254) and two reference fluoroquinolones

Dwight J. Hardy, R. N. Swanson, Dena M. Hensey, +5

Antimicrobial Agents and Chemotherapy

Antimicrobial ChemotherapyPharmaceutical ChemistryDrug ResistanceMedicinal ChemistryComparative Antibacterial Activities +15

Bioassay for A-56268 (TE-031) and identification of its major metabolite, 14-hydroxy-6-O-methyl erythromycin

Prabhavathi Fernandes, N Ramer, Richard A. Rode, +1

European Journal of Clinical Microbiology & Infectious Diseases

Major MetaboliteBiochemistryMedicineSecondary MetaboliteNatural Product Biosynthesis +4

In vitro evaluation of ABT-719, a novel DNA gyrase inhibitor

Robert K. Flamm, C Vojtko, D. T. W. CHU, +6

Antimicrobial Agents and Chemotherapy

Staphylococcus AureusPharmacotherapyAntimicrobial ChemotherapyDrug ResistanceMedicinal Chemistry +19

In vivo evaluation of A-56619 (difloxacin) and A-56620: new aryl-fluoroquinolones

Prabhavathi Fernandes, D. T. W. CHU, Robert R. Bower, +3

Antimicrobial Agents and Chemotherapy

Pharmaceutical ScienceNew Aryl-fluoroquinolonesEscherichia ColiAntimicrobial ChemotherapyPharmaceutical Chemistry +15

A-61827 (A-60969), a new fluoronaphthyridine with activity against both aerobic and anaerobic bacteria

Prabhavathi Fernandes, D. T. W. CHU, R. N. Swanson, +5

Antimicrobial Agents and Chemotherapy

Legionella PneumophilaEscherichia ColiAntimicrobial ChemotherapyAntibiotic ResistanceAnaerobic Culturing +19

Susceptibility testing of macrolide antibiotics against Haemophilus influenzae and correlation of in vitro results with in vivo efficacy in a mouse septicemia model

Prabhavathi Fernandes, Dwight J. Hardy, Robert T. Bailer, +5

Antimicrobial Agents and Chemotherapy

H. InfluenzaeAntimicrobial SusceptibilityAntibioticsSusceptibility TestingVeterinary Science +13

In vitro and in vivo evaluations of A-80556, a new fluoroquinolone

Jacob J. Clement, S. Ken Tanaka, J. D. Alder, +6

Antimicrobial Agents and Chemotherapy

Pharmaceutical ScienceEscherichia ColiPharmacotherapyAntimicrobial ChemotherapyPharmaceutical Chemistry +17

Effect of dosing intervals on efficacy of clarithromycin and erythromycin in mouse infection models.

Fernandes Pb, Swanson Rn, Hardy Dj, +2

PubMed

PharmacotherapyAntimicrobial ChemotherapyNew MacrolideDrug ResistanceToxicology +14